ORTEXORTEX News
Tracking EC? Get live short interest, options flow, and signals on ORTEX.Sign up free →
EC
Earnings PreviewEC

Jefferies Doubles EC's Target Days Before Q3 Print

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 2 min readdata as of 31 Oct 2026, 04:03

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

Ecopetrol reports Q3 results on November 3, and the most striking pre-earnings move came from the analyst community rather than from short sellers or options traders.

Jefferies upgraded the Colombian state oil company from Underperform to Hold on October 29, just two trading sessions before the print, and more than doubled its price target from $9 to $19. That puts the new Jefferies target above the current price of $17.19, a notable shift for a firm that had been one of the more bearish voices on the name. The broader analyst consensus remains at Hold with a mean target of $14.66, well below where the stock trades today, though that consensus reflects a cluster of Neutral ratings from UBS, Citi and JP Morgan that have been drifting higher through the year as the stock recovered. The gap between the consensus target and the current price is worth noting: most of the Street still sees the stock as fairly to slightly overvalued at current levels, even after the Jefferies reversal.

The debate around Ecopetrol is less about the oil market and more about Colombian political risk. The Petro government's rhetoric on energy nationalization and environmental restrictions has weighed on the stock for much of the year, and dividend sustainability has become a recurring concern given that payout policy is partly subject to government direction. On the other side, earnings-based valuation remains cheap: the P/E is around 8.3x and the earnings yield factor ranks in the 92nd percentile of the ORTEX coverage universe. For investors willing to look past the political noise, that is a compelling multiple for an integrated producer of this scale.

Short positioning does not add much drama to the setup. Shares short have risen about 10% over the past week, but without a float percentage figure available the absolute level is difficult to frame precisely. Borrow costs are low at 1.3% and falling, down roughly 26% on the week. Availability is comfortable at 142%, meaning there are well over two shares available to borrow for every one currently lent out, nowhere near the 1% low recorded earlier in the 52-week window. Options positioning is similarly relaxed: the put/call ratio of 0.64 is only marginally above its 20-day average of 0.61, less than half a standard deviation away, suggesting no particular hedging urgency into the number.

Past earnings reactions have been consistently negative on the day: the last four prints all produced day-one declines, ranging from 0.5% to 2.7%, though the five-day drift has been mixed. The November 3 print will test whether the Jefferies upgrade and the stock's month-long 4% recovery reflect a genuine re-rating of the political risk, or whether the earnings figures themselves give the market a reason to revisit the consensus skepticism on the target price.

Stocks in this article

See the live data behind this article on ORTEX.

Open EC on ORTEX →

How this article was generated

Generated
31 Oct 2026, 04:22
Data as of
31 Oct 2026, 04:03
Prompt version
v1.0
Data sources
Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notes
Validation notes
  • soft: missing section mentions: short interest (informational only)

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.